Personal Kinetigraph (PKG)
Device Parkinson's Disease
PDI 09369998308569
General payments
$115,483
Research payments
$248,960
Through program year 2023, $115,483 in general payments and $248,960 in research payments were reported against Personal Kinetigraph (PKG) (Parkinson's Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $91,633 | 14 |
| 2023 | Research | $48,015 | 27 |
| 2022 | Research | $39,484 | 12 |
| 2021 | General | $23,850 | 11 |
| 2021 | Research | $161,461 | 26 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
25 general · 65 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.